ProKidney hosts KOL event to review rilparencel mechanism of action data

PROK•2026-10-22

ProKidney will host a virtual key opinion leader event on October 27, 2026, at 10:30 a.m. ET, covering rilparencel’s mechanism of action and potential role in advanced chronic kidney disease with type 2 diabetes.

1. Virtual event planned

Nephrologist Katherine Tuttle will provide clinical perspectives, and ProKidney management will deliver a corporate update.

ProKidney hosts KOL event to review rilparencel mechanism of action data

1. Virtual event planned

Related News

Unusual Machines receives $16.9 million drone components order from Powerus

Redington Gulf signs strategic collaboration agreement with AWS for AI adoption in META region

Mexico's inflation accelerates more than expected in early October

AbbVie's skin disease drug reduces lesions in trial, company eyes weight-loss combination

TriMas declares quarterly cash dividend of $0.04 per share